Northwest Quadrant Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,712
| Closed | -$273K | – | 71 |
|
|
2025
Q1 | $273K | Buy |
3,712
+32
| +0.9% | +$2.35K | 0.06% | 49 |
|
|
2024
Q4 | $241K | Sell |
3,680
-1
| -0% | -$66 | 0.05% | 63 |
|
|
2024
Q3 | $287K | Buy |
3,681
+8
| +0.2% | +$623 | 0.07% | 49 |
|
|
2024
Q2 | $286K | Hold |
3,673
| – | – | 0.07% | 47 |
|
|
2024
Q1 | $249K | Sell |
3,673
-496
| -12% | -$33.6K | 0.06% | 53 |
|
|
2023
Q4 | $281K | Hold |
4,169
| – | – | 0.07% | 48 |
|
|
2023
Q3 | $282K | Buy |
4,169
+13
| +0.3% | +$880 | 0.08% | 41 |
|
|
2023
Q2 | $297K | Sell |
4,156
-24
| -0.6% | -$1.72K | 0.08% | 42 |
|
|
2023
Q1 | $290K | Buy |
4,180
+51
| +1% | +$3.54K | 0.08% | 43 |
|
|
2022
Q4 | $280K | Hold |
4,129
| – | – | 0.09% | 47 |
|
|
2022
Q3 | $226K | Buy |
4,129
+14
| +0.3% | +$766 | 0.07% | 50 |
|
|
2022
Q2 | $270K | Hold |
4,115
| – | – | 0.08% | 48 |
|
|
2022
Q1 | $274K | Buy |
4,115
+28
| +0.7% | +$1.86K | 0.08% | 50 |
|
|
2021
Q4 | $238K | Hold |
4,087
| – | – | 0.06% | 57 |
|
|
2021
Q3 | $244K | Sell |
4,087
-231
| -5% | -$13.8K | 0.07% | 55 |
|
|
2021
Q2 | $260K | Hold |
4,318
| – | – | 0.07% | 52 |
|
|
2021
Q1 | $215K | Buy |
4,318
+37
| +0.9% | +$1.84K | 0.07% | 60 |
|
|
2020
Q4 | $215K | Hold |
4,281
| – | – | 0.07% | 56 |
|
|
2020
Q3 | $236K | Buy |
4,281
+17
| +0.4% | +$937 | 0.09% | 51 |
|
|
2020
Q2 | $226K | Hold |
4,264
| – | – | 0.1% | 48 |
|
|
2020
Q1 | $225K | Buy |
4,264
+43
| +1% | +$2.27K | 0.1% | 48 |
|
|
2019
Q4 | $211K | Buy |
+4,221
| New | +$211K | 0.09% | 65 |
|